Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cocrystal Pharma Inc (COCP)
NASDAQ:COCP
Cocrystal Pharma (COCP) Stock Price & Analysis
978 Followers
COCP Stock Chart & Stats
Day’s Range$1.5 - $1.59
52-Week Range― - ―
Previous Close$1.56
Volume3.85K
Average Volume (3M)N/A
Market Cap
$15.89M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next Earnings
May 13, 2024EPS Estimate
-$0.54Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$10.00Price Target Upside542.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Cocrystal Pharma News
PremiumCompany Announcements
Cocrystal Pharma Advances Influenza A Treatment Development
PremiumPre-Earnings
Is COCP a Buy, Before Earnings?
Bulls Say, Bears Say
Bulls Say
Clinical Trial ResultsCC-42344 showed antiviral activity against various influenza A strains with favorable pharmacokinetic and safety profiles.
Market OpportunityMassive market opportunity remains in treating influenza.
Regulatory DevelopmentsRegulatory input received on future CC-42344 clinical path.
Bears Say
Collaboration HaltMerck determined that there were no existing conditions to continue the collaboration.
Development ChallengesThe termination resulted from the inability to develop the compounds to meet a specific aspect of Merck’s program.
Partnership TerminationEstablished pharmaceutical partner terminates collaboration—lowering price target.
---
Ownership Overview
88.80%
Insiders
3.32% Mutual Funds
2.64% Other Institutional Investors
5.24% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
COCP FAQ
What was Cocrystal Pharma Inc’s price range in the past 12 months?
Currently, no data Available
What is Cocrystal Pharma Inc’s market cap?
Currently, no data Available
When is Cocrystal Pharma Inc’s upcoming earnings report date?
Cocrystal Pharma Inc’s upcoming earnings report date is May 13, 2024 which is in 18 days.
How were Cocrystal Pharma Inc’s earnings last quarter?
Cocrystal Pharma Inc released its earnings results on Mar 28, 2024. The company reported -$0.32 earnings per share for the quarter, beating the consensus estimate of -$0.597 by $0.277.
Is Cocrystal Pharma Inc overvalued?
According to Wall Street analysts Cocrystal Pharma Inc’s price is currently Undervalued.
Does Cocrystal Pharma Inc pay dividends?
Cocrystal Pharma Inc does not currently pay dividends.
What is Cocrystal Pharma Inc’s EPS estimate?
Cocrystal Pharma Inc’s EPS estimate is -$0.54.
How many shares outstanding does Cocrystal Pharma Inc have?
Currently, no data Available
What happened to Cocrystal Pharma Inc’s price movement after its last earnings report?
Cocrystal Pharma Inc reported an EPS of -$0.32 in its last earnings report, beating expectations of -$0.597. Following the earnings report the stock price went down -6.667%.
Which hedge fund is a major shareholder of Cocrystal Pharma Inc?
Currently, no hedge funds are holding shares in COCP
---
Cocrystal Pharma Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$10.00 (542.71% Upside)
$10.00 (542.71% Upside)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 5.5%
Last 30 Days ▼ 5.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.87%
12-Months-Change
Fundamentals
Return on Equity
-54.54%
Trailing 12-Months
Asset Growth
-23.46%
Trailing 12-Months
Company Description
Cocrystal Pharma Inc
Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded on January 2, 2014 and is headquartered in Bothell, WA.
---
COCP Stock 12 Months Forecast
Average Price Target
$10.00
▲(542.71% Upside)
Technical Analysis
Best Analysts Covering COCP
1 Year
1 Year Success Rate
2/16 ratings generated profit
1 Year Average Return
-27.21%
reiterated a buy rating 22 days ago
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 12.50% of your transactions generating a profit, with an average return of -27.21% per trade.
---